Frequency of irregular antibodies in patients from a second-level hospital in the Huasteca Potosinaal in the Huasteca Potosina
Keywords:
Alloimmunization, Blood bank, Erythrocyte compatibility, Blood transfusionAbstract
Blood compatibility tests required for transfusions include ABO/Rh blood group typing, crossmatch tests (major and/or minor), and detection of irregular antibodies. Irregular antibodies can develop in patients previously exposed to erythrocyte membrane antigens and may trigger immune reactions upon subsequent exposure. These reactions can lead to adverse transfusion effects, such as reduced survival of transfused erythrocytes due to hemolysis, ranging from moderate to severe severity. This study conducted a retrospective review of irregular antibody screening performed in 2021 on patients treated at the Blood Bank of the General Hospital of Ciudad Valles. The results showed a frequency of irregular antibodies of 4 %, with identified antibodies including anti-Lewis (25%), anti-E (17%), anti-c (17%), anti-Duffy A (8%), and 33% unidentified. Additionally, data indicated that female patients exhibited a higher prevalence of alloimmunization compared to males, accounting for 83.3% of cases. The percentage of positive screenings observed exceeds the national average established by the Mexican Official Standard NOM 253-SSA1-2012. Proper identification of patients with irregular antibodies reduces the risk of adverse transfusion reactions in the short and long term. Understanding the primary irregular antibodies present in the population provides essential guidance for developing safe and effective transfusion protocols to benefit patients.
Downloads
References
Alanazi, F. M. (2024). Prevalence of ABO, Rh, and Kell Antigens Among Blood Donors in Al-Qurayyat Region. Clinical Laboratory, 70(12), 2290–2298. https://doi.org/10.7754/CLIN.LAB.2024.240710
Ali-Pérez, N. A., Matos-Bayeau, A. A., & Rodríguez-Ruiz, M. (2019). Reacción transfusional hemolítica retardada por aloanticuerpo anti-E. Revista Información Científica, 98(1), 98–105. http://scielo.sld.cu/scielo.phpscript=sci_arttext&pid=S1028-99332019000100098&lng=es&nrm=iso&tlng=es
Bencomo-Hernández, A. A., Rojas, S. A., González-Díaz, I., Monteagudo, A. C., Morera-Barrios, L. M., & Leyva, R. R. (2016). Red blood cell antigens and antibodies in patients awaiting renal transplantation. In Revista Cubana de Hematología, Inmunol y Hemoter (Vol. 32, Issue 2). http://scielo.sld.cu
Bonilla-Zavala, R., Sánchez-Huerta, R., Rivera-López, R., & Ambriz- Fernández, R. (2011). Enfermedad hemolítica del recién nacido poranti-c y anti-E. Revista Mexicana de Medicina Transfusional, 4(1), 10–13.
Castillo-Macías, A., Díaz-Chuc, E., Sotelo-Coronado, J., Llaca-Díaz, J., Avilés-Rodríguez, L., Pérez-Chávez, F., Cázares-Tamez, R., Mercado-Del Ángel, F., Castillo-Macías, A., Díaz-Chuc, E., Sotelo-Coronado, J., Llaca-Díaz, J., Avilés-Rodríguez, L., Pérez-Chávez, F., Cázares-Tamez, R., & Mercado-Del Ángel, F. (2018). Anticuerpos anti-Fya con reacción anamnésica asociada con anti-D en transfusión intrauterina: reporte de un caso. Ginecología y Obstetricia de México, 86(2), 158–163. https://doi.org/10.24245/GOM.V86I2.1550
Arthur, C.M., Olsson, L.M., & Stowell, S.R. (2023). ABO and Other Carbohydrate Blood Group Systems. In Cohn, C., Delaney, M., Johnson, S.T., Katz, L.M., & Schwartz, J. (Ed.), AABB Technical Manual (21st ed., pp. 303–336). Association for the Advancement of Blood & Biotherapies.
Contelli, H. S., de Oliveira, M. C., Ido, A. A. S., Francalanci, E. M., Terra, P. O. da C., Filho, E. R., Batistão, D. W. da F., & Royer, S. (2024). Assessment of erythrocyte alloimmunization among patients treated at a Brazilian
university hospital. Hematology, Transfusion and Cell Therapy, 46, S128–S135. https://doi.org/10.1016/J.HTCT.2024.04.128
del Peón-Hidalgo, L., Pacheco-Cano, M. G., Zavala-Ruiz, M., Madueño-López, A., & García-González, A. (2002). Frecuencias de grupos sanguíneos e incompatibilidades ABO y RhD, en La Paz, Baja California Sur, México. Salud Pública de México, 44(5), 406–412.
Diario Oficial de la Federación. (2012, October). Norma Oficial Mexicana NOM-253-SSA1-2012, Para la disposición de sangre humana y sus componentes con fines terapéuticos. https://www.gob.mx/cms/uploads/attachment/file/219069/NOM-
-SSA1-2012_Para_la_disposicion_de_sangre_humana_y_sus_componentes_con_fines_terapeuticos.pdf
Diario Oficial de la Federación. (2016, April 7). Norma Oficial Mexicana NOM-007-SSA2-2016, Para la atención de la mujer durante el embarazo, parto y puerperio, y de la persona recién nacida. https://www.dof.gob.mx/nota_detalle.php?codigo=5432289&fecha=07/04/2016#gsc.tab=0
INEGI. (2023). Estadísticas a propósito del día internacional de la mujer. Javiera-Fuenzalida, C., & Jorge-Carvajal, A. C. (2014). Manejo de la embarazada con isoinmunización por anticuerpos irregulares. Revista Chilena de Obstetricia y Ginecología, 79(4), 315–322. https://doi.org/10.4067/S0717-75262014000400011
Koelewijn, J. M., Vrijkotte, T. G. M., Van Der Schoot, C. E., Bonsel, G. J., & De Haas, M. (2008). Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion, 48(5), 941–952. https://doi.org/10.1111/J.1537-2995.2007.01625.X
Lacarriere-Mejía, D., Ruiz Velazco-Benítez, Y. A., & Vázquez-Parrodi, M. (2022). Guía de Práctica Clínica: Atención y cuidados
multidisciplinarios en el embarazo (Centro Nacional de Excelencia Tecnológica en Salud, Ed.).
Malagón-Martínez, A. (2007). Guía para el uso clínico de la sangre (R. A. Marín y López, Ed.; 3rd ed.). Secretaría de Salud.
Mejía-Aguirre, B., Palomino-Morales, R., Linares-Ramírez, V., & Jiménez- González, M. D. C. (2018). Frecuencia de anticuerpos irregulares y factores asociados en pacientes con patología cardiaca. In Rev Mex Med Tran (Vol. 11, Issue 1).
Miller, S. T., Kim, H. Y., Weiner, D. L., Wager, C. G., Gallagher, D., Styles, L. A., Dampier, C. D., & Roseff, S. D. (2013). Red blood cell alloimmunization in sickle cell disease: Prevalence in 2010. Transfusion, 53(4), 704–709. https://doi.org/10.1111/J.15372995.2012.03796.X
Mosquera-Plata, A. S. (2016). Prevalencia de anticuerpos irregulares en pacientes politransfundidos en el Hospital Pediátrico Baca Ortiz en el período 2012- 2015. Universidad Central del Ecuador.
Organizacion Mundial de la Salud. (2020). Disponibilidad y seguridad de la sangre a nivel mundial.
Peralta-Martínez, Z. del S., Estrada-Díaz, C. A., & González-Hernámdez, Y. T. (2015). Importancia de anticuerpos irregulares en medicina transfusional [Universidad Nacional Autónoma de Nicaragua]. https://repositorio.unan.edu.ni/id/eprint/1037/1/61304.pdf
Pogo, A. O., & Chaudhuri, A. (2000). The duffy protein: A malarial and chemokine receptor. Seminars in Hematology, 37(2), 122–129. https://doi.org/10.1016/S0037-1963(00)90037-4
Py, J. Y. (2010). Choix des concentrés érythrocytaires délivrés par les dépôts et sécurité transfusionnelle immunologique. Transfusion Clinique et Biologique, 17(5–6), 334–340. https://doi.org/10.1016/J.TRACLI.2010.09.166
Red Cell Immunogenetics and Blood Group Terminology | ISBT Working Party| The International Society of Blood Transfusion (ISBT). (n.d.). Retrieved January 28, 2025, from https://www.isbtweb.org/isbt-
working-parties/rcibgt.html
Ribed-Sánchez, B., González-Gaya, C., Varea-Díaz, S., Corbacho-Fabregat, C., Bule-Farto, I., & Pérez de-Oteyza, J. (2018). Analysis of economic and social costs of adverse events associated with blood transfusions in Spain. Gaceta Sanitaria, 32(3), 269–274. https://doi.org/10.1016/J.GACETA.2017.10.021
Vázquez, J., Vassallo, E., & Storino, M. (2002). Reacciones Postransfusionales. Revista de La Facultad de Medicina, 25(2), 154–
Wu, H., Li, R., Wei, H., Zhu, W., & Xing, Y. (2024). Clinical Characteristics and Prognosis of Hemolytic Disease of the Newborn Caused by Irregular Antibodies: A 13-Year Retrospective Analysis. Children 2024, Vol. 11, Page 1409, 11(12), 1409. https://doi.org/10.3390/CHILDREN11121409
Xie, J. H., Chong, J. H., Huang, X., Wang, W., Dong, Z., Li, T. T., Li, L. X., & Wu, L. N. (2019). [Result analysis of irregular erythrocyte antibodyscreening]. Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology, 35(5), 457–459. https://doi.org/10.12047/J.CJAP.5807.2019.099
Downloads
Published
Data Availability Statement
They have not been previously published.
Issue
Section
Categories
License
Copyright (c) 2025 QUIBIOUAS, Journal of Biological Chemical Sciences
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
